3650--554-26-2-570-1646 Emergency Pharmacy 5 Lenalidomide 36F79720D0227 36C25926F0100 PO 554-A60293
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically NETWORK CONTRACT OFFICE 19, has issued an Award Notice and Justification for an emergency procurement of Lenalidomide, a critical cancer treatment medication. This award, valued at $587,007.48, was made to EXELAN PHARMACEUTICALS INC on February 5, 2026, under FSS Contract 36F79720D0227.
Purpose & Justification
This procurement was deemed an urgent and compelling need due to patients being at imminent risk of treatment interruption and the pharmacy's insufficient inventory of Lenalidomide. EXELAN PHARMACEUTICALS INC was identified as the sole manufacturer and dispenser of the required generic brand. Market research did not identify any other capable sources, including veteran-owned small businesses, justifying the limited source acquisition.
Contract Details
- Awardee: EXELAN PHARMACEUTICALS INC (Boca Raton, FL)
- Award Amount: $587,007.48
- Award Date: February 5, 2026
- Contract Vehicle: FSS Contract Number 36F79720D0227 (Multiple-Award Schedule Program)
- Delivery/Task Order Number: 36C25926F0100
- Period of Performance (Delivery): February 5, 2026, to February 8, 2026
- Authority: RFO Subpart 538.7104-3(b)(1)(i) for urgent and compelling needs.
- Product/Service Code: 3650 (Chemical And Pharmaceutical Products Manufacturing Machinery)
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
Evaluation & Pricing
Pricing was evaluated as fair and reasonable at the base contract level, representing the best value given the critical nature of the medication and the lack of alternative sources.
Additional Notes
This notice serves to inform the public of an emergency award made under urgent circumstances. It highlights the process and rationale for sole-source procurements when critical patient care is at risk.